BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30343483)

  • 21. Interventions to Address Potentially Inappropriate Prescribing in Community-Dwelling Older Adults: A Systematic Review of Randomized Controlled Trials.
    Clyne B; Fitzgerald C; Quinlan A; Hardy C; Galvin R; Fahey T; Smith SM
    J Am Geriatr Soc; 2016 Jun; 64(6):1210-22. PubMed ID: 27321600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP(3)S-tool.
    Tommelein E; Mehuys E; Petrovic M; Somers A; Van Damme C; Pattyn E; Mattelin K; Boussery K
    Int J Clin Pharm; 2016 Oct; 38(5):1063-8. PubMed ID: 27503282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial.
    Martin P; Tamblyn R; Ahmed S; Benedetti A; Tannenbaum C
    Trials; 2015 Jun; 16():266. PubMed ID: 26058676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPs' perspectives on prescribing for older people in primary care: a qualitative study.
    Riordan DO; Byrne S; Fleming A; Kearney PM; Galvin R; Sinnott C
    Br J Clin Pharmacol; 2017 Jul; 83(7):1521-1531. PubMed ID: 28071806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.
    Barry HE; Cooper JA; Ryan C; Passmore AP; Robinson AL; Molloy GJ; Darcy CM; Buchanan H; Hughes CM
    J Alzheimers Dis; 2016 Apr; 52(4):1503-13. PubMed ID: 27079714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria.
    Cooper JA; Moriarty F; Ryan C; Smith SM; Bennett K; Fahey T; Wallace E; Cahir C; Williams D; Teeling M; Hughes CM
    Eur J Clin Pharmacol; 2016 May; 72(5):583-91. PubMed ID: 26820292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
    Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
    Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the GheOP
    Foubert K; Muylaert P; Mehuys E; Somers A; Petrovic M; Boussery K
    Acta Clin Belg; 2020 Dec; 75(6):388-396. PubMed ID: 31241000
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.
    Uhl MC; Muth C; Gerlach FM; Schoch GG; Müller BS
    BMC Fam Pract; 2018 Jan; 19(1):3. PubMed ID: 29304725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stakeholder perceptions of and attitudes towards problematic polypharmacy and prescribing cascades: a qualitative study.
    Jennings AA; Doherty AS; Clyne B; Boland F; Moriarty F; Fahey T; Hally L; Kennelly SP; Wallace E
    Age Ageing; 2024 Jun; 53(6):. PubMed ID: 38851215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.
    O Riordan D; Aubert CE; Walsh KA; Van Dorland A; Rodondi N; Du Puy RS; Poortvliet RKE; Gussekloo J; Sinnott C; Byrne S; Galvin R; Jukema JW; Mooijaart SP; Baumgartner C; McCarthy V; Walsh EK; Collet TH; Dekkers OM; Blum MR; Kearney PM
    BMJ Open; 2018 Mar; 8(3):e019003. PubMed ID: 29567842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
    Auta A; Strickland-Hodge B; Maz J
    Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact.
    Hill-Taylor B; Sketris I; Hayden J; Byrne S; O'Sullivan D; Christie R
    J Clin Pharm Ther; 2013 Oct; 38(5):360-72. PubMed ID: 23550814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.
    Tommelein E; Mehuys E; Petrovic M; Somers A; Colin P; Boussery K
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1415-27. PubMed ID: 26407687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
    Wheeler A; Crump K; Lee M; Li L; Patel A; Yang R; Zhao J; Jensen M
    Res Social Adm Pharm; 2012; 8(3):179-92. PubMed ID: 21831724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining influences on antibiotic prescribing by nurse and pharmacist prescribers: a qualitative study using the Theoretical Domains Framework and COM-B.
    Courtenay M; Rowbotham S; Lim R; Peters S; Yates K; Chater A
    BMJ Open; 2019 Jun; 9(6):e029177. PubMed ID: 31221892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polypharmacy, potentially inappropriate prescribing and medication complexity in Turkish older patients in the community pharmacy setting.
    Sayın Z; Sancar M; Özen Y; Okuyan B
    Acta Clin Belg; 2022 Apr; 77(2):273-279. PubMed ID: 33031002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'It's showed me the skills that he has': pharmacists' and mentors' views on pharmacist supplementary prescribing.
    Lloyd F; Parsons C; Hughes CM
    Int J Pharm Pract; 2010 Feb; 18(1):29-36. PubMed ID: 20405593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community pharmacists' experiences in mental illness and addictions care: a qualitative study.
    Murphy AL; Phelan H; Haslam S; Martin-Misener R; Kutcher SP; Gardner DM
    Subst Abuse Treat Prev Policy; 2016 Jan; 11():6. PubMed ID: 26821700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.